期刊文献+

住院心力衰竭患者合并心房纤颤的回顾性分析

Hospitalized patients with chronic heart failure complicated by atrial fibrillation:retrospective analysis of 1180 cases
下载PDF
导出
摘要 目的分析近20年慢性心力衰竭(CHF)住院患者合并心房纤颤(AF)的构成比例及相关疾病随时段的变化趋势,栓塞情况,抗栓治疗状况。方法入选近20年(1983-2002年)CHF患者(年龄≥45岁)1180例(合并AF440例),每5年为一个时段,采用回顾性分析的方法。结果总体CHF患者中,合并AF的比例为37.3%,女性多于男性(1.18/1),且随着时段的推移而显著增加(趋势χ2=8.88;P<0.01)。CHF合并AF合并相关疾病的比例依次为冠状动脉粥样硬化性心脏病(CHD)、风湿性心脏病(RHD)、高血压病(HT)、糖尿病(DM)、扩张性心脏肌病(DCM)、肺源性心脏病(PHD)。CHD、HT、DM在CHF合并AF患者中的比例随时段呈显著增加的趋势(P<0.05)。而PHD在CHF合并AF患者中的比例随时段呈显著减少的趋势(P<0.01)。CHD合并HT、CHD合并DM和CHD、HT合并DM是CHF合并AF最常见的多个相关疾病组合。CHF合并AF发生栓塞为21例(占4.8%),使用阿司匹林治疗227例(51.6%),使用华法林治疗38例(8.6%)。结论AF随着时段的推移,该比例呈增加的趋势。注重CHD、HT、DM的早期防治,对于预防CHF合并AF的发生有十分重要的价值。 Objectives To explore the trend of the constitutent ratio of atrial fibrillation (AF) in hospitalized cases of chronic heart failure (CHF), and to analyse the change of the related diseases, embolism and state of anti-embolus treatment of these patients. Methods A total of 1 180 hospitalized cases of CHF (440 complicated with AF) were enrolled during the past 20 years (1983-2002). Every five years were regarded as a period and retrospective analysis was performed. Results The incidence of AF in all cases of CHF was 37.3%, and was higher in females than in males (1.18/1). It increased gradually as time went by (χ^2=8. 88; P〈0. 01). The rates of related diseases in cases of CHF complicated by AF in turn were coronary heart disease (CHD, 43.0%), rheumatic heart disease (RHD, 42.5 %), hypertension (HT, 35.9%), diabetes rnellitus (DM, 13%), dilated cardiomyopathy (DCM, 4. 1%) and pulmonary heart disease (PHD, 3.9%). The rates of CHD, HT and DM in cases of CHF complicated by AF increased markedly (P〈0.05), while that of PHD decreased markedly (P〈0.01) with progression of time periods. CHD and HT, CHD and DM, CHD, HT and DM were the most common combination of multiple related diseases. There were 21 cases complicated by embolism (4. 8% ). The rate of using aspirin was 51.6% and that of warfarin was 8.6%. Conclusions The proportion of AF in cases of CHF was high, and increased significantly as time went by. Paying much attention to the prevention and treatment of CHD, HT and DM in early stage is very important for prevention of AF in cases of CHF.
出处 《中华老年多器官疾病杂志》 2007年第4期257-260,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
基金 天津市科委重点资助项目(编号:033111311)
关键词 心力衰竭 心房颤动 病人 回顾性研究 heart failure atrial fibrillation patients retrospective study
  • 相关文献

参考文献10

  • 1[1]Young JB.The global epidemiology of heart failure.Med Clin North Am,2004,88:1135-1143.
  • 2[2]Savelieva I,John CA.Atrial fibrillation and heart failure:natural history and pharmacological treatment.Europace,2004,5 (Suppl):S5-S19.
  • 3程康安,吴宁.中国部分地区1980、1990、2000年慢性心力衰竭住院病例回顾性调查[J].中华心血管病杂志,2002,30(8):450-454. 被引量:361
  • 4周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 5[7]Stewart S,Hart CL,Hole DJ,et al.A populationbased study of the long-term risks associated with atrial fibrillation:20-year follow-up of the Renfrew/Paisley Study.Am J Med,2002,113:359-364.
  • 6[8]Go AS,Hylek EM,Phillips KA,et al.Prevalence of diagnosed atrial fibrillation in adults.National implications for rhythm management and stroke prevention:the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.JAMA,2001,285:2370-2375.
  • 7[9]Maisel WH,Stevenson LW.Atrial fibrillation in heart failure:epidemiology,pathophysiology,and rationale for therapy.Am J Cardiol,2003,91:2D-8D.
  • 8李小鹰,刘亮,刘德新,司全金,郑秋丽,范利.老年充血性心力衰竭住院患者病因状况调查[J].中华老年多器官疾病杂志,2004,3(1):31-33. 被引量:32
  • 9[11]Allessie MA,Boyden PA,Camm AJ,et al.Pathophysiology and prevention of atrial fibrillation.Circulation,2001,103:769-777.
  • 10杜昕,刘晓惠,马长生.心房颤动的药物治疗[J].中华心律失常学杂志,2005,9(2):129-132. 被引量:33

二级参考文献32

  • 1Kalon KL,Joan LP, William BK. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol, 1993,22 (Suppl A):6A-13A.
  • 2Hung YT, Cheug NT, Ip S. Epidemiology of heart failure in Hong Kong,1997. Hong Kong Med J, 2000,6:159-162.
  • 3Packer M, Coats AJS, Fowler MB, et al. For the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effects of carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001, 344:1651-1658.
  • 4Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Eur Heart J, 2001, 22: 1527-1561.
  • 5Hunt HA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the international society for heart and lung transplantation. Circulation, 2001, 104:2996-3007.
  • 6Walraven C,Hart RG,Singer DE,et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation An individual patient meta-analysis. JAMA, 2002,288: 2441-2448.
  • 7Go AS,Hylek EM,Chang Y,et al. Anticoagulation therapy for stroke prevention in atrial fibrillation. How well do randomized trials translate into clinical practice? JAMA,2003,290:2685 -2692.
  • 8Wang TJ,Massaro JM,Levy D,et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community The Framingham Heart Study.JAMA ,2003,290:1049-1056.
  • 9SPORTIF Ⅲ investigators. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF Ⅲ): randomized controlled trial. Lancet, 2003, 362: 1691-1698.
  • 10Wattigney WA,Mensah GA,Croft JB. Increasing trends in hospitalization for atrial fibrillation in the united states, 1985 through 1999 implications for primary prevention. Circulation,2003,108 :711-716.

共引文献1810

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部